Dossier
Legislative
introduced
other
doctrine
resolution
introduced
proposed rule
passed chamber
executive action
final rule
enacted
district opinion
circuit opinion
opinion
Prices on the Wall Act of 2026
Key claim: The Prices on the Wall Act of 2026 (HR9390) was ordered to be reported as amended by a 24–21 committee vote.
Abstract
(HR9390 · 119th Congress) Latest action (2026-07-21): Ordered to be Reported (Amended) by the Yeas and Nays: 24 - 21.
Why this matters
Price-transparency legislation like HR9390 could reshape how manufacturers, PBMs, or providers disclose drug prices to patients and payers, potentially affecting what consumers see at the point of sale. Committee passage on a near-party-line 24–21 vote signals contested but active movement on transparency-based approaches to drug cost policy, distinct from direct price-setting mechanisms.